메뉴 건너뛰기




Volumn 4, Issue 3, 2005, Pages 295-298

Therapeutic targets of misguided T cells in systemic lupus erythematosus

Author keywords

[No Author keywords available]

Indexed keywords

ATLIZUMAB; CD20 ANTIBODY; CD40 LIGAND MONOCLONAL ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; GLUCOCORTICOID; HYBRID PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6 ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; METHOTREXATE; MONOCLONAL ANTIBODY; PREDNISOLONE; PROTEIN KINASE C THETA; RITUXIMAB; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ZETA CHAIN; TRANSCRIPTION FACTOR ELF 1; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

EID: 21044431923     PISSN: 1568010X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568010054022060     Document Type: Review
Times cited : (9)

References (61)
  • 3
    • 0029994333 scopus 로고    scopus 로고
    • Kotzin, B.L. Cell, 1996, 85, 303.
    • (1996) Cell , vol.85 , pp. 303
    • Kotzin, B.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.